Sleep Tracking
Sleep Tracking
Consumer sleep tracking is the use of a smartwatch, smart ring or phone app to estimate how long and how well a person slept. Adoption is now mass-market: roughly half of US adults (48% in the AASM's 2025 survey, up from 35% in 2023) and ~40% of UK adults track their sleep. The devices are sold as a way to hit the population "sweet spot" of about 6.4-7.8 hours identified by the 2026 Nature ageing-clock study (see Sleep Duration and Mortality).
What the devices measure
| Device | Signals | Derived estimates |
|---|---|---|
| Phone app | Movement, sound (sometimes breathing rate from audio) | Time asleep, disturbances |
| Watch / band | Accelerometry + photoplethysmography (reflected light through skin) | Heart rate, breathing rate, sleep/wake, stage |
| Ring | As watch, plus skin temperature | As watch, plus temperature trends |
None measures brain activity. Polysomnography (PSG) — electrodes for eye movement, EEG, muscle tone and heart rate in a sleep lab — is the gold standard everything is validated against.
How accurate they are
Evidence base: Robbins et al., Sensors 24(20):6532, October 2024 (doi 10.3390/s24206532), testing Oura Ring Gen3, Fitbit Sense 2 and Apple Watch Series 8 against PSG.
- Sleep vs wake: sensitivity ≥95% for all three devices, but precision 72.7-87.8% — the devices reliably catch sleep and also label some wakefulness as sleep. The Economist's "agree with PSG around 95% of the time" rounds this up; the study wins.
- Four-stage classification (wake / light / deep / REM): Cohen's kappa 0.65 Oura, 0.60 Apple Watch, 0.55 Fitbit — "moderate to substantial" agreement. The Economist renders this as ~50-80% agreement and quotes Robbins' grade of "C+ to B+". Devices nonetheless fold stage estimates into headline sleep scores, which are therefore less trustworthy than the duration number.
Reference point: two human PSG scorers typically agree only ~80% of the time, so stage agreement has a ceiling well below 100%.
Do they change behaviour?
- AASM 2025 survey (n=2,007 US adults): 55% of tracker users said they changed their behaviour after seeing their data.
- A small 2020 study in the Journal of Clinical Sleep Medicine found a week of tracker use improved self-reported sleep quality. No objective-outcome trial is cited.
- Clinicians quoted by The Economist view trackers positively on balance: they give an objective time-asleep figure and often reassure people who are in fact sleeping enough.
The downside
A minority of users develop Orthosomnia — anxiety about the data itself — and worry about sleep is itself one of the most common causes of a sleepless night. The Economist's bottom line: the best indicator of a good night is waking up feeling rested, which needs no device.
Open questions
- No trial yet links tracker use to an objectively measured improvement in sleep or health outcomes.
- The 30% orthosomnia prevalence quoted by The Economist is unverified against the AASM's published figures.
- Stage-level metrics (and the "sleep scores" built on them) are not yet accurate enough to act on individually.
Related
- Should You Use a Sleep Tracker (Economist) — 2026-06-06 source.
- Is Too Much Sleep as Bad as Too Little (Economist) — the duration target trackers are sold against.
- Sleep Duration and Mortality · Orthosomnia
Research notes, not medical advice. Findings are reported with the population, dose and duration they were measured in; whether they transfer to you is a question for a clinician.